Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Non-cash Items (2016 - 2025)

Traws Pharma's Non-cash Items history spans 13 years, with the latest figure at $456900.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $456900.0 for Q4 2025, down 83.07% from a year ago — trailing twelve months through Dec 2025 was $456900.0 (down 83.07% YoY), and the annual figure for FY2025 was $456900.0, up 19.63%.
  • Non-cash Items for Q4 2025 was $456900.0 at Traws Pharma, up from $407646.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $2.7 million in Q4 2024 to a low of $6000.0 in Q1 2022.
  • The 5-year median for Non-cash Items is $432273.0 (2025), against an average of $744395.0.
  • The sharpest move saw Non-cash Items crashed 92.82% in 2021, then surged 12747.62% in 2024.
  • Year by year, Non-cash Items stood at $519000.0 in 2021, then crashed by 55.2% to $232488.0 in 2022, then crashed by 90.97% to $21000.0 in 2023, then surged by 12747.62% to $2.7 million in 2024, then plummeted by 83.07% to $456900.0 in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $456900.0, $407646.0, and $407066.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.